Benzinga | Oct 28, 2021 05:26AM EDT

Raymond James Maintains Outperform on CME Group, Raises Price Target to $230

Raymond James analyst Patrick O'Shaughnessy maintains CME Group (NASDAQ:CME) with a Outperform and raises the price target from $225 to $230.